Man Group PLC Gilead Sciences, Inc. Transaction History
Man Group PLC
- $49.7 Billion
- Q2 2025
A detailed history of Man Group PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Man Group PLC holds 1,574,955 shares of GILD stock, worth $195 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
1,574,955
              Previous 1,664,588
              
        
           5.38%
        
      
          
        Holding current value
$195 Million
            Previous $187 Million
            
        
           6.38%
        
      
          
        % of portfolio
0.35%
            Previous 0.5%
          
        Shares
	  30 transactions
	
  Others Institutions Holding GILD
# of Institutions
2,338Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M- 
    
      Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.22% of portfolio
- 
    
      State Street Corp Boston, MA59.2MShares$7.34 Billion0.25% of portfolio
- 
    
      Capital World Investors Los Angeles, CA46.3MShares$5.75 Billion0.78% of portfolio
- 
    
      Wellington Management Group LLP Boston, MA37.5MShares$4.66 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...